Download PDF

Pharmaceutical Growth Opportunities in Brazil, Russia, India and China: Healthcare reform, market dynamics and key players

Positive economic growth, stabilizing political structures, growing patient populations and increasing direct foreign investment in the emerging markets of Brazil, Russia, India and China (BRIC) are creating significant opportunities for pharmaceutical companies to expand into these markets and maximize future revenue potential. Pharmaceutical sales across the BRIC economies grew by 22.3%in 2005, compared to single digit growth in the major markets of the US, Europe and Japan. This new report provides an in-depth insight into the competitive dynamics of the BRIC markets. The political and regulatory environments are evaluated and healthcare systems assessed, enabling you to understand the determinants crucial to your success in these high growth markets. Benchmark your growth strategies against the top pharmaceutical companies operating in the BRIC markets, align your portfolio with future market opportunity and identify lucrative partnering opportunities to ensure you maximize the potential from these promising markets.

View Table Of Contents >